aTyr Pharma, Inc. - Penyata Pendapatan (TTM)

aTyr Pharma, Inc.
US ˙ NasdaqCM ˙ US0021202025

Penyata Pendapatan (TTM)

aTyr Pharma, Inc. Penyata Pendapatan menunjukkan perubahan dalam pendapatan dan perbelanjaan sepanjang tempoh masa tertentu. Data Penyata Pendapatan termasuk Jualan dan Hasil, Untung Kasar, Penyelidikan dan Pembangunan (R&D), Jualan, Perbelanjaan Am dan Pentadbiran (SG&A), Pendapatan Operasi, Perbelanjaan Cukai Pendapatan, Perbelanjaan Faedah, Pendapatan Bukan Operasi, Perolehan sesaham (EPS), dan Saham Diterbitkan.

Semua nombor adalah kali 1,000,000 kecuali setiap unit saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Hasil 9 10 2 2 2 10 10 10 11 0 1 1 0 0 0 0
Perubahan (%) 22.34 -77.14 -7.91 -6.72 405.89 0.00 0.00 3.40 -96.71 66.57 0.00 -60.03 0.00 -100.00 NaN
% daripada Hasil 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Kos jualan 16 17 18 21 22 43 34 44 44 42 46 50 55 54 53 54
Perubahan (%) 6.85 5.21 18.11 2.43 94.52 -20.48 29.24 1.03 -4.85 9.42 8.93 8.90 -0.96 -2.85 2.67
% daripada Hasil 189.36 165.38 761.13 976.15 1,071.94 412.17 327.76 423.61 413.89 11,981.02 7,870.41 8,573.30 23,361.28 23,137.02
Keuntungan Operasi Kasar -8 -7 -16 -19 -20 -32 -24 -24 -24 -42 -46 -50 -55 -54 -53 -54
Perubahan (%) -10.49 131.14 22.04 3.47 62.48 -27.04 2.98 0.41 71.47 8.94 9.05 9.72 -0.96 -2.43 2.67
% daripada Hasil -89.36 -65.38 -661.13 -876.15 -971.94 -312.17 -227.76 -234.55 -227.76 -11,881.02 -7,770.41 -8,473.30 -23,261.28 -23,037.02
SG&A 9 9 9 10 10 14 14 14 13 13 13 13 13 14 14 16
Perubahan (%) -2.38 1.06 7.02 5.56 34.95 -0.53 1.93 -6.88 -1.68 0.76 -2.88 5.41 2.90 3.28 11.15
% daripada Hasil 108.78 86.80 383.72 445.93 504.68 134.62 133.91 136.50 122.93 3,676.77 2,224.15 2,160.20 5,697.45 5,862.55
R&D 9 9 9
Perubahan (%) 0.00 0.00
% daripada Hasil 89.06 89.06 86.13
OpEx 25 26 27 31 32 57 57 58 58 55 59 63 68 68 67 70
Perubahan (%) 3.48 3.78 14.39 3.41 75.45 0.72 1.70 -0.90 -4.12 7.39 6.33 8.20 -0.20 -1.61 4.47
% daripada Hasil 298.14 252.19 1,144.85 1,422.08 1,576.62 546.79 550.73 560.11 536.82 15,657.79 10,094.56 10,733.50 29,058.72 28,999.57
Pendapatan operasi -17 -16 -25 -29 -30 -46 -47 -48 -47 -55 -59 -63 -68 -68 -67 -70
Perubahan (%) -6.04 56.95 16.53 4.18 53.07 0.88 2.08 -1.84 17.07 7.01 6.39 8.84 -0.20 -1.27 4.47
% daripada Hasil -198.14 -152.19 -1,044.85 -1,322.08 -1,476.62 -446.79 -450.73 -460.11 -436.82 -15,557.79 -9,994.56 -10,633.50 -28,958.72 -28,899.57
Perbelanjaan Faedah
Perubahan (%)
% daripada Hasil
Pendapatan bersih -17 -16 -25 -29 -30 -45 -45 -45 -43 -50 -54 -58 -64 -64 -63 -67
Perubahan (%) -6.03 54.88 15.70 3.67 50.42 -0.45 -0.18 -4.23 16.78 7.03 7.36 10.22 0.32 -0.95 5.09
% daripada Hasil -202.02 -155.18 -1,051.38 -1,320.90 -1,468.14 -436.53 -434.59 -433.80 -401.81 -14,274.50 -9,171.60 -9,846.43 -27,155.74 -27,243.83

Source: Capital IQ

Other Listings
DE:471A €4.72
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista